Currently, researchers can genetically intervene with erythropoietin at the molecular level and better express the gene locus for anemia treatment, suggesting that rhEPO is effective for both surgery and cancer-related anemia (Nguyen et al., 2013; Cao et al., 2020). Here, EPO is linked to anemia.